pentobarbital will minimize the level or influence of armodafinil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Unidentified.Keep track of Closely (1)pentobarbital will reduce the level or impact of buprenorphine subdermal implant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep trac